Subscribe: Bionity.COM News
http://www.bionity.com/news/e/feed.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  brain  cancer  cell  cells  disease  drug  life  merck  new  patent  research  researchers  scientists  stem  university 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Bionity.COM News

Untitled





 



Sartorius and Science magazine to award prize for regenerative medicine and cell therapy

Wed, 28 Jun 2017 14:00:07 +0200

Sartorius together with the Science magazine will award a Sartorius & Science Prize for Regenerative Medicine & Cell Therapy. This prestigious annual award is geared towards exceptional scientists who focus on achieving advancements in basic or translational research in these areas. All scientists w...



Heptares enters a Research and Drug Discovery Collaboration with New York University

Wed, 28 Jun 2017 14:00:04 +0200

Heptares Therapeutics announces the launch of a new research collaboration under its ORBIT initiative with New York University (NYU) School of Medicine. This new collaboration will support a multi-year programme with NYU’s drug discovery accelerator group, the Office of Therapeutics Alliances (OTA) ...



Multifunctional catalyst for poison-resistant hydrogen fuel cells

Wed, 28 Jun 2017 11:11:43 +0200

(image)
Japanese collaboration develops catalyst that can oxidize both hydrogen and carbon monoxide to produce energy Demand for eco-friendly fuel sources is increasing as the goal of weaning off our reliance on fossil fuels becomes commonly recognized. Hydrogen represents a possible sustainable fuel source...



Bioconjugation specialist Innova Biosciences acquired by SYGNIS AG

Wed, 28 Jun 2017 07:00:15 +0200

Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, has announced it has been fully acquired by SYGNIS AG, for EUR 8 million in cash and 3.5 million in shares. Innova’s range of antibody and protein labeling products and services ideally complements SYGNIS’ cu...



NRL issued patent for solar microbial fuel cell

Wed, 28 Jun 2017 07:00:14 +0200

(image)
The U.S. Naval Research Laboratory (NRL), Center for Biomolecular Science and Engineering, has received a U.S. patent for a self-assembling, self-repairing, and self-contained microbial photoelectrochemical solar cell driven entirely by sunlight and microorganisms. A solar microbial fuel cell (SMFC)...



This year’s research prize awarded by Eppendorf goes to the United Kingdom

Tue, 27 Jun 2017 14:00:06 +0200

(image)
In 2017, the Hamburg life science company is presenting its research prize for the 22nd time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Dr. Tom Baden, Senior Lecturer in Neuroscience at the University of Sussex, Brighton, United Kingdom, as the 2017 winner of the E...



Lonza has received all regulatory approvals for acquisition of Capsugel

Tue, 27 Jun 2017 14:00:04 +0200

Lonza announced that it has received all regulatory approvals for the proposed acquisition of Capsugel S.A. by Lonza. With all final regulatory approvals in place, Lonza can now complete the transaction, which is expected to close in the next days subject to the satisfaction of customary closing con...



Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue

Tue, 27 Jun 2017 14:00:02 +0200

Sun Pharma and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare ,  New  Delhi announced that they have signed an agreement for testing phytopharmaceutical, biologic and chemi...



Protein mingling under blue light

Tue, 27 Jun 2017 07:00:13 +0200

(image)
One of the current challenges in biology is to understand rapidly-changing phenomena. Interestingly, only a small fraction of them is due to proteins acting in isolation, the majority of biological events are regulated by proteins acting together in clusters. Researchers at the Center for Cognition ...



Ecology insights improve plant biomass degradation by microorganisms

Tue, 27 Jun 2017 07:00:12 +0200

Microbes are widely used to break down plant biomass into sugars, which can be used as sustainable building blocks for novel biocompounds. Getting the right microbial community for this process is still a matter of trial and error. New insights by University of Groningen microbial ecologist Dr Diego...



Select memories can be erased, leaving others intact

Tue, 27 Jun 2017 07:00:10 +0200

(image)
Different types of memories stored in the same neuron of the marine snail Aplysia can be selectively erased, according to a new study by researchers at Columbia University Medical Center (CUMC) and McGill University. The findings suggest that it may be possible to develop drugs to delete memories th...



Eurofins acquires clinical diagnostics company in Italy

Mon, 26 Jun 2017 14:00:04 +0200

Eurofins Scientific announces that it has signed an agreement to acquire Genoma Group Srl in Italy. The transaction is expected to close in the next few weeks, subject to customary closing conditions. With 20 years of clinical testing innovation, Genoma offers a wide range of specialty diagnostic te...



More durable, versatile wearable for diabetes monitoring

Mon, 26 Jun 2017 14:00:00 +0200

(image)
Researchers at The University of Texas at Dallas are getting more out of the sweat they've put into their work on a wearable diagnostic tool that measures three diabetes-related compounds in microscopic amounts of perspiration. "Type 2 diabetes affects so many people. If you have to manage and regul...



Bacterial organizational complexities revealed

Mon, 26 Jun 2017 07:00:11 +0200

(image)
For the first time, scientists have visualized the fine details of bacterial microcompartment shells - the organisms' submicroscopic nanoreactors, which are comprised completely of protein. The results show how the architectural principles of bacterial microcompartments, or BMCs, apply to both "good...



How do genes get new jobs?

Mon, 26 Jun 2017 07:00:09 +0200

(image)
Amid the incredible diversity of living things on our planet, there is a common theme. Organisms need to acquire new genes, or change the functions of existing genes, in order to adapt and survive. How does that happen? A common view is that genes duplicate, with one of the copies picking up a new f...



Tiny nanoparticles offer significant potential in detecting and treating disease

Mon, 26 Jun 2017 07:00:00 +0200

(image)
Exosomes - tiny biological nanoparticles which transfer information between cells - offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded. Areas which could benefit include cancer treatment and regenerative medici...



Eurofins expands its footprint in the Balkan region

Fri, 23 Jun 2017 14:00:05 +0200

Eurofins Scientific announces that it has signed an agreement to acquire Environmental Research & Industrial Co-operation (“ERICo”), the leading independent laboratory for environment testing services in Slovenia. As the largest private environment testing laboratory in the country, ERICo provides a...



Waters Corporation elects Flemming Ornskov to Board of Directors

Fri, 23 Jun 2017 14:00:04 +0200

Waters Corporation announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. "It is an honor to welcome Flemming Ornskov to our Board of Directors," said Christopher J. O'Connell, Waters Corporation President and CEO....



State-of-the-art text mining technologies for chemistry

Fri, 23 Jun 2017 11:11:59 +0200

(image)
The Biological Text Mining Unit at the Spanish National Cancer Research Centre (CNIO) together with with researchers at the Center for Applied Medical Research (CIMA), of the University of Navarra, in Pamplona, and the Barcelona Supercomputing Centre (BSC-CNS) have published the first exhaustive rev...



New mechanism for genome regulation found

Fri, 23 Jun 2017 07:00:18 +0200

(image)
The same mechanisms that quickly separate mixtures of oil and water are at play when controlling the organization in an unusual part of our DNA called heterochromatin, according to a new study by researchers at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab). Research...



New sensors could enable more affordable detection of pollution and diseases

Fri, 23 Jun 2017 07:00:08 +0200

When it comes to testing for cancer, environmental pollution and food contaminants, traditional sensors can help. The challenges are that they often are bulky, expensive, non-intuitive and complicated. Now, one team reports in ACS Sensors that portable pressure-based detectors coupled with smartphon...



Clear view on stem cell development

Thu, 22 Jun 2017 18:37:12 +0200

(image)
Today, tracking the development of individual cells and spotting the associated factors under the microscope is nothing unusual. However, impairments like shadows or changes in the background complicate the interpretation of data. Now, researchers at the Technical University of Munich (TUM) and the ...



New femto-camera with quadrillion fractions of a second resolution

Thu, 22 Jun 2017 14:00:04 +0200

(image)
Researchers from ITMO University have built a setup for recording holograms of tiny objects like living cells with a femtosecond speed. The new method allows one to reconstruct phase topography of a studied sample according to deformations that emerge in a laser pulse when it passes through the spec...



Shimadzu acquires specialist for isotope labeled standards

Thu, 22 Jun 2017 11:25:27 +0200

Shimadzu has joined forces with the France-based AlsaChim company, an independent contract research and development organization. AlsaChim specializes in stable isotope-labelled compounds, metabolites and pharmaceutical related substances, and analytical purposes. With immediate effect, Shimadzu Eur...



Otto Hahn Medal for Jaime Agudo-Canalejo

Thu, 22 Jun 2017 10:19:53 +0200

(image)
Im Rahmen der 68. Jahreshauptversammlung der Max-Planck-Gesellschaft (MPG), die  am 21. und 22. Juni in Weimar, Jena und Erfurt stattfindet, erhält der Nachwuchswissenschaftler vom Max-Planck-Institut für Kolloid- und Grenzflächenforschung die Otto-Hahn-Medaille. Er wird für seine herausragende Dokt...



Supply chains key to Life Sciences transformation

Thu, 22 Jun 2017 07:00:15 +0200

Advanced supply chains could be the vital catalyst for transforming Life Sciences to better meet increasing demand cost-effectively, says a new report by DHL. The report ‘Future of Life Sciences and Healthcare Logistics’ highlights the urgency for the sector to transform in response to evolving pati...



Myelo Therapeutics conducts successful Pre-IND meeting with FDA

Thu, 22 Jun 2017 07:00:10 +0200

Myelo Therapeutics GmbH announced that it successfully conducted a Pre-IND (Investigational New Drug) meeting with the FDA Center for Drug Evaluation and Research (CDER) on May 11th, 2017 for Myelo001, a novel, orally bioavailable small molecule to prevent myelosuppression caused by chemotherapy. Fo...



Infections in Early Life Associated with Increased Risk for Celiac Disease

Thu, 22 Jun 2017 07:00:08 +0200

(image)
Infections during infancy are associated with increased risk for gluten intolerance (celiac disease) later on. Apparently the risk is particularly high in the case of repeated gastrointestinal infections in the first year of life. This conclusion was drawn by scientists of the Institute for Diabetes...



Distant Brain Regions Selectively Recruit Stem Cells

Wed, 21 Jun 2017 14:00:00 +0200

(image)
Stem cells persist in the adult mammalian brain and generate new neurons throughout life. A research group at the Biozentrum of the University of Basel reports in the current issue of "Science" that long-distance brain connections can target discrete pools of stem cells in their niche and stimulate ...



Groundbreaking experimental method will speed up protein analysis substantially

Wed, 21 Jun 2017 11:21:26 +0200

(image)
An international team of scientists has for the first time used an X-ray free-electron laser to unravel the structure of an intact virus particle on the atomic level. The method used dramatically reduces the amount of virus material required, while also allowing the investigations to be carried out ...



How Insulin in the Brain May Suppress the Subjective Feeling of Hunger

Wed, 21 Jun 2017 07:00:21 +0200

(image)
Insulin in the brain may help regulate the hunger sensation and improve functional connectivity in certain cognitive brain regions (default-mode network, DMN) as well as in the hippocampus and hypothalamus. This is the finding of a new study by researchers at the German Center for Diabetes Research ...



Merck creates immuno-oncology spin out iOnctura

Wed, 21 Jun 2017 07:00:13 +0200

Merck announced its corporate venture arm Merck Ventures created iOnctura SA, Geneva, Switzerland. This immuno-oncology spin-out company was formed around two assets from the Healthcare R&D portfolio of Merck and three assets from Cancer Research Technology (CRT). CRT is the commercial arm of Cancer...



Sugar-coated nanomaterial excels at promoting bone growth

Wed, 21 Jun 2017 07:00:03 +0200

There hasn't been a gold standard for how orthopaedic spine surgeons promote new bone growth in patients, but now Northwestern University scientists have designed a bioactive nanomaterial that is so good at stimulating bone regeneration it could become the method surgeons prefer. While studied in an...



Unusual soybean coloration sheds a light on gene silencing

Wed, 21 Jun 2017 07:00:01 +0200

(image)
Today's soybeans are typically golden yellow, with a tiny blackish mark where they attach to the pod. In a field of millions of beans, nearly all of them will have this look. Occasionally, however, a bean will turn up half-black, with a saddle pattern similar to a black-eyed pea. "The yellow color i...



Bacteria Free Themselves with Molecular “Speargun”

Tue, 20 Jun 2017 07:00:14 +0200

(image)
Many bacteria are armed with nano-spearguns, which they use to combat unwelcome competitors or knockout host cells. The pathogen responsible for tularemia, a highly virulent infectious disease, uses this weapon to escape from its prison in cells defending the host. Researchers from the Biozentrum of...



We are much more unique than assumed

Tue, 20 Jun 2017 07:00:12 +0200

(image)
Every human being has a unique DNA "fingerprint". In other words, the genetic material of any two individuals can be clearly distinguished. Computational biologists at the Technical University of Munich (TUM) have now determined that the impact of these variations has been greatly underestimated. Th...



New three-in-one blood test opens door to precision medicine for prostate cancer

Tue, 20 Jun 2017 07:00:08 +0200

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes. By testing cancer DNA in the bloodstream, researchers found they could pick out which men with advanced prosta...



MSC unanimously agrees that Bisphenol A is an endocrine disruptor

Mon, 19 Jun 2017 14:00:04 +0200

The Member State Committee (MSC) supported the French proposal to additionally identify Bisphenol A as a substance of very high concern because of its endocrine disrupting properties which cause probable serious effects to human health. The committee also agreed to identify the substance PFHxS as an...



Highlights of June 2017 EMA Management Board meeting

Mon, 19 Jun 2017 14:00:04 +0200

Brexit preparations The Management Board of the European Medicines Agency (EMA) was updated on the Agency’s preparation for the withdrawal of the United Kingdom (UK) from the European Union (EU). Further to the UK’s invocation of Article 50 on 29 March 2017, EMA needs to prepare and is working on th...



PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion

Mon, 19 Jun 2017 14:00:02 +0200

PerkinElmer, Inc. announced that it has entered into a definitive agreement to acquireEUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN. The total purchase price of the transaction based on all outstanding shares being a...



New ISPE Good Practice Guide

Mon, 19 Jun 2017 11:05:59 +0200

The International Society for Pharmaceutical Engineering (ISPE) announced the release of their latest guidance document, ISPE Good Practice Guide: Decommissioning of Pharmaceutical Equipment and Facilities. This guide provides an overview of best practices to be used for the decommissioning and disp...



Modeling the brain with 'Lego bricks'

Mon, 19 Jun 2017 11:01:17 +0200

(image)
Researchers from the University of Luxembourg, in cooperation with the University of Strasbourg, have developed a computational method that could be used to guide surgeons during brain surgery. Surgeons often operate in the dark. They have a limited view of the surface of the organ, and can typicall...



Cardiac stem cells from heart disease patients may be harmful

Mon, 19 Jun 2017 07:00:12 +0200

Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and "miraculous" stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, in fact, harm heart disease patients. The research, led by Prof. Jonathan Leo...



Blocking gene expression to combat deadly fungal infection

Mon, 19 Jun 2017 07:00:08 +0200

(image)
Each year, invasive fungal infections sicken an estimated 2 million people worldwide and kill nearly 800,000 - but a team of international scientists have discovered a new approach for antifungal drug treatments. Researchers from USC and France identified that a gene-regulating protein, Bdf1, is cri...



Investigation tests drug to activate immune system, help fight cancer

Fri, 16 Jun 2017 14:00:04 +0200

(image)
On Earth, research into antibody-drug conjugates to treat cancer has been around a while. The research presents a problem, though, because Earth-based laboratories aren't able to mimic the shape of the cancer cell within the body, which can sometimes produce incorrect findings. The International Spa...



Research on crucial cutting enzyme maps sites of DNA damage in leukemias and other cancers

Fri, 16 Jun 2017 14:00:03 +0200

Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors. The enzyme, type II topoi...



Crescendo Biologics appoints new Chief Business Officer

Fri, 16 Jun 2017 07:00:16 +0200

Crescendo Biologics Ltd (Crescendo) announced that Edward J. “Tad” Stewart has joined the company as Chief Business Officer. Dr. Peter Pack, CEO of Crescendo Biologics commented: “Crescendo’s platform is delivering a robust pipeline of intrinsically differentiated, multi-functional therapeutics in ...



Drug design strategy boosts the odds against resistance development

Fri, 16 Jun 2017 07:00:08 +0200

(image)
A new rational drug design technique that uses a powerful computer algorithm to identify molecules that target different receptor sites on key cellular proteins could provide a new weapon in the battle against antibiotic resistance, potentially tipping the odds against the bugs. The technique, which...



A mechanical trigger for toxic tumor therapy

Fri, 16 Jun 2017 07:00:04 +0200

Cells in nearly any part of the body can become cancerous and transform into tumors. Some, like skin cancer, are relatively accessible to treatment via surgery or radiation, which minimizes damage to healthy cells; others, like pancreatic cancer, are deep in the body and can only be reached by flood...



Merck awarded its first CRISPR patent by Australian Patent Office

Thu, 15 Jun 2017 14:00:05 +0200

(image)
Merck announced that the Australian Patent Office has granted the company patent rights over the use of CRISPR in a genomic integration method for eukaryotic cells. The patent is the first that Merck, a leader in genome editing, has received for CRISPR technology. The patent covers chromosomal integ...